Eikon Therapeutics inks Series B
Eikon Therapeutics Inc, a California-based drug discovery and development company, has secured $517.8 million in Series B financing.
Eikon Therapeutics Inc, a California-based drug discovery and development company, has secured $517.8 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination